NEW YORK (GenomeWeb News) – Hologic announced today that the US Food and Drug Administration has cleared for marketing the firm's Aprima Trichomonas vaginalis Assay to run on the Panther System.

The assay was previously cleared by the FDA for use on Gen-Probe's Tigris System in April 2011. According to Bedford, Mass.-based Hologic, the assay remains the only FDA-cleared amplified nucleic acid test on the market for detecting Trichomonas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.